Our findings suggest that obesity plays a role in chronic inflammation (as seen in leptin and IL-6 levels modified by BMI) while the additional inflammatory pressure resulting in elevated NOV and EPC levels is likely driven by intermittent hypoxia and inflammation specific to OSA pathophysiology. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.